Christine Gagliardi

Dr. Christine Gagliardi joined ImmunoGenesis as Director, Research and Development, in December 2020 from Bellicum Pharmaceuticals, where she served as Director, Product Development. Other prior industry experience includes research and development roles at Pfizer and Progenitor Cell Therapy. Dr. Gagliardi received a Ph.D. in Biomedical Sciences/Pharmacology from Tulane University and a BS in Molecular, Cellular, and Developmental Biology from Yale University.